Adding Talazoparib to Atezolizumab Maintenance Therapy for SLFN11-Positive Extensive-Stage SCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929
J Thorac Oncol 2024 Nov 04;[EPub Ahead of Print], NA Karim, J Miao, KL Reckamp, CM Gay, LA Byers, YQ Zhao, MW Redman, DR Carrizosa, WL Wang, WJ Petty, K Mehta, BA Faller, ES Agamah, SS Kasbari, RK Malisetti, A Kumar, J Schallenkamp, KC Alluri, JE Gray, K KellyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.